Probenecid and Amlodipine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Probenecid (probenecid) and Amlodipine (amlodipine besylate). Common drug interactions include aplastic anaemia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Probenecid and Amlodipine. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Probenecid?

Probenecid has active ingredients of probenecid. It is often used in gout. eHealthMe is studying from 560 Probenecid users. Check the latest studies of Probenecid.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.



On Jul, 20, 2026

25 people who take Probenecid and Amlodipine together, and have interactions are studied.

Probenecid and Amlodipine drug interactions.

What are the common drug interactions of Probenecid and Amlodipine, by gender? *:

female:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  3. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  4. Chronic kidney disease
  5. Death
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Pneumonia
  9. Renal failure (kidney dysfunction)

male:

  1. Pneumonia
  2. Anxiety
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Dizziness
  6. Fluid overload (too much fluid in the blood)
  7. Haematocrit decreased
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Loss of consciousness
  10. Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage)

What are the common drug interactions of Probenecid and Amlodipine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Injection site pain
  2. Oxygen saturation decreased
  3. Productive cough
  4. Pyrexia (fever)
  5. Respiratory tract congestion (blockage on respiratory system)
  6. Blood testosterone decreased
  7. Disease recurrence
  8. Drug ineffective
  9. Hypoglycaemia (deficiency of glucose in the bloodstream)
  10. Lyme disease (a bacterial infection that is spread to humans by infected ticks)

60+:

  1. Dyspepsia (indigestion)
  2. Pneumonia
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Dizziness
  5. Fluid overload (too much fluid in the blood)
  6. Haematocrit decreased
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Loss of consciousness
  9. Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage)
  10. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the existing conditions these people have? *

  1. Depression: 7 people, 28.00%
  2. Pain: 5 people, 20.00%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 16.00%
  4. High Blood Cholesterol: 4 people, 16.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.00%
  6. Psoriasis (immune-mediated disease that affects the skin): 3 people, 12.00%
  7. Lyme Disease (a bacterial infection that is spread to humans by infected ticks): 3 people, 12.00%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 12.00%
  9. Thyroid Diseases: 2 people, 8.00%
  10. Stress And Anxiety: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Probenecid and Amlodipine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Probenecid and Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Probenecid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Probenecid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amlodipine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on probenecid and amlodipine besylate (the active ingredients of Probenecid and Amlodipine, respectively), and Probenecid and Amlodipine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: